If there’s no such thing as bad publicity, AstraZeneca PLC’s COVID-19 vaccine is doing great, having generated a series of embarrassing events surrounding the rollout in Europe and development in the US.
Now, in an extraordinary move, the Data and Safety Monitoring Board overseeing the US clinical trial has voiced concerns about...







